Filing Details
- Accession Number:
- 0001144204-15-054197
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-09 13:28:30
- Reporting Period:
- 2015-09-08
- Filing Date:
- 2015-09-09
- Accepted Time:
- 2015-09-09 13:28:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 749647 | Celsion Corp | CLSN | Pharmaceutical Preparations (2834) | 521256615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1558526 | Egwu, Inc. Fka Egen, Inc. | 601 Genome Way Suite 3400 Huntsville AL 35806 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-09-08 | 10,000 | $2.11 | 2,462,423 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.14, inclusive. The reporting person undertakes to provide to Celsion Corporation, any security holder of Celsion Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to Form 4.
Billionaire Hedge Funds
